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Abstract
Background: Candida parapsilosis is known to show limited genetic variability, despite different karyotypes and
phenotypes have been described. To further investigate this aspect, a collection of 62 sensu strictu C. parapsilosis
independent isolates from 4 geographic regions (Italy, n = 19; New Zealand, n = 15; Argentina, n = 14; and
Hungary, n = 14) and different body sites (superficial and deep seated) were analysed for their genetic and
phenotypic traits. Amplification fragment length polymorphism (AFLP) analysis was used to confirm species
identification and to evaluate intraspecific genetic variability. Phenotypic characterisation included clinically relevant
traits, such as drug susceptibility, in vitro biofilm formation and aspartyl protease secretion.
Results: AFLP genotyping showed little variation among isolates, when the presence/absence of bands was
considered. However, when AFLP profiles were compared by relative intensity for each fragment, a significant level
of variation and geographical clustering was observed. All isolates were found to be susceptible to commonly used
antifungals, although a reduced susceptibility to echinocandins was observed in all isolates. C. parapsilosis isolates
from different geographic origins varied in the number of biofilm producers, with a higher prevalence of producers
isolated in Hungary and Argentina. The frequency of secreted proteinase producers also varied in isolates obtained
from different areas, with a higher number of proteinase producers found in Italy and New Zealand. Interestingly,
biofilm production and proteinase secretion were negatively correlated. This finding could be explained by
assuming that proteinase activity plays a role in detachment and release from a mature biofilm, via degradation of
C. parapsilosis adhesins and/or extracellular matrix components, as observed for other microorganisms.
Conclusions: The low number of polymorphic AFLP bands (18 out of 80) obtained for C. parapsilosis isolates is in
agreement with the limited sequence variability described for this species. However, when band intensity was
included in the analysis, geographical clustering was observed. Expression of virulence factors varied among strains
isolated from different geographical regions, with biofilm and proteinase producers more frequently isolated from
Hungary and Italy, respectively.
Background
Of the species belonging to the “psilosis” group, Can-
dida parapsilosis is by far the most studied and charac-
terised. It represents about 90% of the infection
attributed to C. parapsilosis sensu lato [1] and it seems
to be better adapted to the human host than the two
relatives (C. orthopsilosis and C. metapsilosis), as also
shown by the high incidence of C. parapsilosis systemic
infection worldwide, assessed as the second most com-
mon candidemia in many countries [2-6]. C. parapsilosis
is an opportunistic pathogen that colonises human skin
and can spread nosocomially through hand carriage
[7,8]. It has been frequently associated with infections in
newborns [6,8,9] and in catheterised patients [3]. This
can be linked to the ability of C. parapsilosis to produce
biofilm in the presence of plastic surfaces such as cathe-
ters or other prosthetic materials [6,10-12].
An increasing number of studies points towards a
reduced genetic variability among C. parapsilosis isolates,
which has been interpreted as a predominant clonal
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mode of reproduction [6,13-15]. This is in contrast to
what has been recently described for C. metapsilosis and
C. orthopsilosis species, in which recombination has been
shown to occur by AFLP analysis [16,17]. On the other
hand, a notable variability in virulence phenotypes has
been observed for C. parapsilosis, such as the ability to
produce biofilm or hydrolytic enzymes [6,18].
In this study, a selection of 62 C. parapsilosis isolates
obtained from different patients was made from a wide
collection of “psilosis” isolates on the basis of different
geographical (Italy, Hungary, Argentina, New Zealand)
and anatomical (blood, mucosa, nail, cerebrospinal fluid,
etc) origins, in order to evaluate if these factors may
have an impact on genetic variability.
AFLP was applied to our entire “psilosis” collection
(n = 650), as this method has been shown to reproduci-
bly and unequivocally identify Candida species
[16,17,19]. The 62 selected isolates were analysed further
by using another enzyme/primer combination EcoRI-
HindIII, since the previously used EcoRI-MseI combina-
tion was found to be less discriminative and affected by
band homoplasy in C. parapsilosis and C. metapsilosis
[unpublished data, [17]]. The EcoRI/HindIII enzyme
combination gives rise to larger fragments and therefore
increases the sensitivity to detect polymorphisms.
In parallel, phenotypic properties such as biofilm for-
mation and proteinase secretion were analysed. Since
the “psilosis” species have been recently associated with
a lower susceptibility to the echinocandin class of anti-
fungals [20,21], drug susceptibility was also evaluated
and extended to other antifungals. The overall goal of
this study was to gain further information on genotypic
and phenotypic properties of this successful and yet elu-
sive opportunistic pathogen.
Methods
Isolates
The Candida parapsilosis collection included 62 indivi-
dual isolates obtained from different body sites and geo-
graphical regions (Table 1). The majority of Italian
isolates (n = 19) was provided by the Unità Operativa di
Microbiologia, Ospedale Universitario, Pisa; 6 isolates
being from different Italian hospitals (Table 1). Hungar-
ian isolates (n = 14) were from the Department of
Microbiology, Medical School, Debrecen. Argentinian
and New Zealand isolates were kindly provided by Dr
Marisa Biasoli, Centro de Referencia de Micologia, Uni-
versity of Rosario and by Dr Arlo Upton, Auckland City
Hospital, respectively. The isolates used in this study
were initially identified as C. parapsilosis according to
their biochemical profile on API32 ID and a Vitek 2
advanced colorimetric semi automated system (bioMér-
ieux, Marcy l’Etoile, France). C. parapsilosis ATCC
22019 was included in the study as reference strain. All
isolates were maintained on Sabouraud agar (Liofilchem
S.r.l., TE, Italy) for the duration of the study.
DNA extraction and molecular typing of Candida
parapsilosis
Genomic DNA was extracted from yeast samples grown
in Sabouraud broth, (Liofilchem) as previously described
[16]. DNA quantity and integrity was assessed by gel
electrophoresis.
AFLP analysis was used to confirm species identifica-
tion and to evaluate the genetic relatedness of C. para-
psilosis isolates. AFLP was performed on 50 ng of
genomic DNA as previously described [16]. The restric-
tion-enzyme combination EcoRI/HindIII was used in the
first restriction/ligation step. The concentration of the
HindIII adaptor was equal to EcoRI (0.45 μM).
Sequences of the adapters and pre-selective primers
used for AFLP analysis were as already reported [17].
Pre-selective, selective amplifications and gel electro-
phoresis conditions were performed as previously
described [16]. AFLP profiles, ranging from 100 to 700
bases, were exported as a TIFF file and analyzed with
the TotalLab TL120 software package (Nonlinear
Dynamics Ltd, UK) to evaluate genetic variability within
the species. DNA bands obtained for each isolate were
size-matched. AFLP bands were defined by time (Rf
value) and by the surface of the fluorescent peak they
form, as recently described [17]. Only bands which were
at least 0.5% of the lane volume present in at least one
of the isolates were included in the analysis. Bands were
considered to be absent as the surface of the peak was
less than 0.03% of the lane volume.
Dendrograms were built by the TL120 software using
the unweighted-pair group method using arithmetic
means (UPGMA). For each pair of isolates, a similarity
index (SAB) was calculated, ranging between 0 (complete
non-identity) and 1.0 (identity). The SAB between the
patterns for every pair of isolates A and B was com-
puted by the formula SAB = 2E/(2E+a+b), where E is the
number of bands shared by both isolates A and B, a is
the number of unique bands in the pattern for isolate A
absent in the pattern for isolate B, and b is the number
of unique bands for isolate B not present in isolate A.
Since C. parapsilosis isolates displayed very little poly-
morphic fragments, but showed a great variation in
band intensity, the latter parameter was included in gen-
otype analysis. Thus, the quantity of each AFLP frag-
ment was normalised as a percentage of the total
quantity of the AFLP fragments for a given isolate and
defined as relative intensity. For each isolate pair, the
Pearson’s correlation of the relative intensities % of all
fragments present in the two isolates was determined: a
correlation index of 1 corresponded to a complete iden-
tical pattern.
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Table 1 Details and phenotypic properties of Candida parapsilosis clinical isolates used in this study
Strain Site of isolation Origin Biofilme 30°C Proteasef 30°C
CP 1 Conjunctiva Pisa (I) 0.006 (NPi) 0.3 (NP)
CP 17 Blood Pisa (I) 0.015 (NP) 1.13 (WP)
CP 24 Blood Pisa (I) 0.003 (NP) 3.0 (MP)
CP 28 Nail Pisa (I) 0.006 (NP) 1.5 (WP)
CP 39 Blood Pisa (I) 0.010 (NP) 1.0 (WP)
CP 42 Blood Pisa (I) 0.042 (WPl) 0.5 (NP)
CP 66 Vaginal swab Pisa (I) 0.001 (NP) 1.0 (WP)
CP 71 Vaginal swab Pisa (I) 0.031 (WP) 1.0 (WP)
CP147a Catether Novara (I) 0.031 (WP) 0.3 (NP)
CP164a Catether Bergamo (I) 0.024 (NP) 3.5 (HP)
CP183a Blood Pavia (I) 0.012 (NP) 5.7 (HP)
CP 191a Blood Catania (I) 0.039 (WP) 1.25 (WP)
CP 192a Blood Catania (I) 0.034 (WP) 1.37 (WP)
CP 210a Blood Verona (I) 0.061 (WP) 2.0 (WP)
CP 243 Catether Pisa (I) 0.019 (NP) 3.0 (MP)
CP 314 Sputum Pisa (I) 0.017 (NP) 3.7 (HP)
CP 498 Vaginal swab Pisa (I) 0.033 (WP) 1.9 (WP)
CP 499 Nail Pisa (I) 0.019 (NP) 0.5 (NP)
CP 502 Oral swab Pisa (I) 0.011 (NP) 4.2 (HP)
CP 425b Blood Auckland (NZ) 0.008 (NP) 4.0 (HP)
CP 426b Blood Auckland (NZ) 0.140 (MPm) 0.6 (NP)
CP 427b Blood Auckland (NZ) 0.040 (WP) 3.2 (HP)
CP 440b Blood Auckland (NZ) 0.060 (WP) 2.0 (WP)
CP 441b Blood Auckland (NZ) 0.031 (WP) 3.7 (HP)
CP 448b Blood Auckland (NZ) 0.127 (MP) 1.5 (WP)
CP 455b Biopsy Auckland (NZ) 0.416 (HPn) 0.2 (NP)
CP 459b CAPDg Auckland (NZ) 0.027 (NP) 2.2 (MP)
CP 471b Vaginal swab Auckland (NZ) 0.042 (WP) 1.0 (WP)
CP 476b Vaginal swab Auckland (NZ) 0.230 (HP) 0.7 (NP)
CP 477b Vaginal swab Auckland (NZ) 0.032 (WP) 2.8 (MP)
CP 479b Nail Auckland (NZ) 0.021 (NP) 2.25 (MP)
CP 480b Nail Auckland (NZ) 0.120 (MP) 1.2 (WP)
CP 481b Nail Auckland (NZ) 0.005 (NP) 3.0 (MP)
CP 486b Urogenital swab Auckland (NZ) 0.006 (NP) 2.0 (WP)
CP 540c Faeces Rosario (RA) 0.006 (NP) 2.5 (MP)
CP 541c Urine Rosario (RA) 0.015 (NP) 2.0 (WP)
CP 543c Blood Rosario (RA) 0.049 (WP) 0.5 (NP)
CP 544c Blood Rosario (RA) 0.111 (MP) 0.5 (NP)
CP 545c Liquor Rosario (RA) 0.046 (WP) 0.5 (NP)
CP 546c Biopsy Rosario (RA) 0.048 (WP) 1.3 (WP)
CP 550c Liquorh Rosario (RA) 0.100 (MP) 0.5 (NP)
CP 551c Liquor Rosario (RA) 0.058 (WP) 1.7 (WP)
CP 552c Liquor Rosario (RA) 0.047 (WP) 1.2 (WP)
CP 553c Liquor Rosario (RA) 0.033 (WP) 0.5 (NP)
CP 554c Blood Rosario (RA) 0.031 (WP) 1.5 (WP)
CP 555c Blood Rosario (RA) 0.101 (MP) 1.2 (WP)
CP 556c Faeces Rosario (RA) 0.078 (WP) 1.7 (WP)
CP 558c Absess Rosario (RA) 0.093 (MP) 1.0 (WP)
CP 510d Blood Debrecen (H) 0.083 (MP) 0.7 (NP)
CP 511d Blood Debrecen (H) 0.170 (HP) 0.1 (NP)
CP 512d Catether Debrecen (H) 0.167 (HP) 0.2 (NP)
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A distance matrix was obtained by subtracting the
correlation between two AFLP patterns from 1 (dis-
tance = 1-correlation). This distance matrix was
imported into the Treefit program [22] and used to pro-
duce a UPGMA dendrogram, which was visualised with
the Treeview program [23,24].
Biofilm formation
Biofilm production by C. parapsilosis clinical isolates
was evaluated as previously described [16,17]. One set of
plates was incubated at 37°C and another at 30°C with-
out agitation. After 24 h, plates were washed and the
optical density was measured (OD at 450 nm). Biofilm
production was considered as absent (no production;
NP), when the OD at 450 nm was lower than 0.03,
weak (WP, 0.03 ≤ OD < 0.08), moderate (MP, 0.08 ≤
OD < 0.16), or high (HP, OD ≥ 0. 16) [16].
Proteinase secretion assay
Yeasts were pre-grown in YEPD liquid medium (2% glu-
cose, 1% yeast extract and 2% bactopepton, Difco,
Detroit, MI, USA). C. parapsilosis isolates were analyzed
for secreted proteolytic activity on solid medium con-
taining bovine serum albumin (BSA) as the sole nitrogen
source. The inducing medium containing 1.17% yeast
carbon base (Difco); 0.01% yeast extract (Biolife, Milan,
Italy); 0.2% BSA (pH 5.0) (BDH, Poole, UK) was steri-
lised by filtration and added to a solution of autoclaved
(2%) agar. The number of blastoconidia was microscopi-
cally determined and yeast suspensions were adjusted to
106cells/ml. Ten μl of each yeast suspension was inocu-
lated in duplicate onto BSA agar plates and incubated at
30°C for 7 days. Proteolysis was determined by amido
black staining of the BSA present in the medium as
described by Ruchel and colleagues [25]. Proteinase
activity was considered to be absent when no
clarification of the medium around the colony was visi-
ble (radius of proteolysis < 1 mm), weak when a clear
zone was visible (1 ≤ radius < 2 mm), moderate when
the clarification radius was comprised between 2 and
3 mm and high, when the proteolytic halo exceeded
3 mm in radius.
Antifungal susceptibility
The colorimetric broth micro dilution method Sensiti-
treYeastOne® (YO-9, Trek Diagnostic Systems Inc., Cle-
veland, USA) was used to evaluate C. parapsilosis
susceptibility to amphotericin B, fluconazole, posacona-
zole, itraconazole, voriconazole, 5-flucytosine and the
echinocandins (caspofungin, micafungin, anidulafungin)
as previously described [17]. According to manufacture
instructions, the positive growth well was examined
after 24 hour incubation. If the well was red, endpoint
for antifungal could be interpreted, otherwise plates
were incubated for a further 24 hours.
Antifungal susceptibility interpretation criteria were
according to the Clinical Laboratory Standards Institute
(CLSI) M27-A3 and M27-S3 documents [26,27]. Briefly,
caspofungin MIC ≤ 2 (μg/ml) susceptible (S) and > 2
(μg/ml) non susceptible; fluconazole MIC ≤ 8 (μg/ml) S,
MIC between 16 and 32 (μg/ml) susceptible dose depen-
dent (S-DD), MIC ≥ 64 (μg/ml) resistant (R); itracona-
zole MIC ≤ 0.125 (μg/ml) S, MIC between 0.25 and 0.5
(μg/ml) S-DD, MIC ≥ 1 (μg/ml) R; voriconazole MIC ≤
1 (μg/ml) S, MIC = 2 (μg/ml) S-DD, MIC ≥ 4 (μg/ml)
R; amphotericin B MIC ≤ 1 (μg/ml) S; 5-flucytosine
MIC ≤ 4 (μg/ml) S, MIC between 8 and 16 (μg/ml)
intermediate (I), MIC ≥ 32 (μg/ml) R [25,26]. For S-DD
category, susceptibility is dependent on achieving the
maximal possible blood level of the antifungal [26,27].
C. parapsilosis reference strain ATCC 22019 was used
as control.
Table 1 Details and phenotypic properties of Candida parapsilosis clinical isolates used in this study (Continued)
CP 514d Blood Debrecen (H) 0.180 (HP) 0.5 (NP)
CP 521d Urine Debrecen (H) 0.058 (WP) 0.7 (NP)
CP 523d Oral swab Debrecen (H) 0.163 (PP) 0.5 (NP)
CP 524d Ear swab Debrecen (H) 0.049 (WP) 1.1 (WP)
CP 525d Blood Debrecen (H) 0.078 (WP) 1.0 (WP)
CP 527d Blood Debrecen (H) 0.032 (WP) 2.5 (MP)
CP 528d Sputum Debrecen (H) 0.009 (NP) 1.5 (WP)
CP 530d Wound Debrecen (H) 0.069 (WP) 1.1 (WP)
CP 531d Urine Debrecen (H) 0.037 (WP) 0.5 (NP)
CP 533d Catether Debrecen (H) 0.191 (HP) 0.4 (NP)
CP 536d Catether Debrecen (H) 0.162 (HP) 0.9 (NP)
aStrains CP147, 164, 183, 191, 192, 210 were kindly provided by Prof. G. Morace; bNew Zealand, cArgentinean and dHungarian isolates were generously given by
Dr Arlo Upton, Dr Marisa Biasoli and Dr Laszlo Majoros, respectively. eOptical density (OD l450 nm) of biofilm production. Biofilm was scored as absent when OD
at 450 nm< 0.03. fRadius of proteolysis. Proteinase activity was considered absent when no clarification of the agar around the colony was visible (radius of
proteolysis ≤ 1 mm). gCAPD stands for continuous ambulatory peritoneal dialysis. hLiquor stands for cerebrospinal fluid. iNP, non producer; lWP, weak producer;
mMP, moderate producer; nHP, high producer.
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Statistics
Statistical analysis was performed using Instat software
(GraphPad, USA). One-way ANOVA followed by Post-
hoc test (Bonferroni) was used to evaluate the level of
statistical significance of clustering. The association
between biofilm and proteinase production was deter-
mined by Pearson’s correlation coefficient (r). Differ-
ences between proteinase/biofilm producers versus non
producers were examined using Fisher’s exact test.
A P value < 0.05 was considered statistically significant.
Results
Molecular typing of Candida parapsilosis isolates
AFLP was used to confirm correct species identification
and to evaluate genetic variability within the selected
62 C. parapsilosis isolates. AFLP profiles obtained for
C. parapsilosis consisted of 80 fragments ranging from
100 to 700 bases. Fragments larger than 700 bases were
used as a control of DNA integrity. The number of
monomorphic fragments was 62, which were common
to all C. parapsilosis isolates. Therefore, these fragments
were considered species specific and used for identifica-
tion. Indeed, as shown in Figure 1A, which includes a
wider panel of clinical isolates, this method allowed us
to identify the presence of C. metapsilosis and C. tropi-
calis (CP542, CP534, CP557), which were excluded from
this study. Identification of C. tropicalis and C. metapsi-
losis was performed by comparing AFLP profiles with
those of 16 different fungal reference species [[16], data
not shown].
Figure 1 displays the AFLP profiles obtained from sev-
eral C. parapsilosis isolates including those selected for
Figure 1 AFLP patterns. (A) AFLP profiles obtained from the molecular screening of 48 putative Candida parapsilosis clinical isolates and
reference strains ATCC 22019 (C. parapsilosis), ATCC 96139 (C. orthopsilosis) and ATCC 96143 (C. metapsilosis). In bold, isolates used in this study
for genotyping and phenotyping isolated from Argentina (CP540-558) and Hungary (510-536). M 50-500 base molecular weigh standard. In
italics, the non-parapsilosis isolates identified during the AFLP screening. (B) AFLP profiles of 34 C. parapsilosis strains isolated from Italy (CP1-
CP502) and New Zealand (CP425-486). At the top of the figure, reference strains for C. metapsilosis (ATCC 96143) C. orthopsilosis (ATCC 96139)
and C. parapsilosis (ATCC 22019) are included.
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the study and isolated from Argentina, Hungary (Figure
1A), Italy, and New Zealand (Figure 1B). When the pre-
sence/absence of fragments was the only parameter con-
sidered in AFLP analysis, very little genotypic diversity
within the isolate collection was found (Figure 1A-B). In
fact, the majority of AFLP markers included in the ana-
lysis (n = 80) were monomorphic, with only 18 poly-
morphic fragments. In agreement, UPGMA analysis
indicated that all isolates grouped together, with a simi-
larity index (SAB) higher than 0.96 (Figure 2A). A
further level of analysis was performed to calculate a
genetic distance between each isolate pair by the Pear-
son product-moment correlation coefficient (r), based
on relative “intensity” of all fragments, which also takes
into account the presence/absence of bands. Different
band intensity was independent from DNA template
concentration [data not shown; [28]], as expected, since
AFLP is limited by primer concentration.
With this type of analysis, significant geographic clus-
tering of the isolates was observed (Figure 2B). One-way
ANOVA with Post-hoc test (Bonferroni) showed that all
clustering above 0.04 (correlation coefficient of 0.96)
were highly significant (P < 0.001). Reproducibility of
the AFLP analysis was 97%, estimated by the average
correlation among duplicated samples of reference
C. parapsilosis strain (data not shown).
Drug susceptibility
All C. parapsilosis isolates were found to be susceptible
to the antifungals included in the SensititreYeastOne®
Y09 panel, with the exception of CP558 that displayed a
dose-dependant susceptibility to fluconazole (MIC =
16 μg/ml). MIC values (μg/ml) were as follows: 5-flucy-
tosine 0.06 ≤ MIC ≤ 0.25 (mean 0.127 ± 0.084 SD);
posaconazole 0.008 ≤ MIC ≤ 0.5 (mean 0.069 ± 0.07
SD); voriconazole 0.008 ≤ MIC ≤ 0.5 (mean 0.037 ±
Figure 2 AFLP profile analysis. (A) UPGMA dendrogram based on presence/absence of AFLP fragments. (B) UPGMA dengrogram based on
genetic distances derived from correlation coefficients including differences in relative band intensities. Geographical origin of isolates is
indicated by I, Italy; RA, Argentina; NZ, New Zealand; and H, Hungary.
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0.064 SD); itraconazole, 0.003 ≤ MIC ≤ 0.25 (mean 0.07
± 0.036 SD); fluconazole, 0.125 ≤ MIC ≤ 16 (mean 1.8
± 1.7 SD); amphotericin B, 0.125≤MIC≤ 1 (mean 0.44 ±
0.18 SD).
All C. parapsilosis isolates exhibited a reduced sus-
ceptibility to the echinocandin class, with the following
MICs: anidulafungin, 0.5 ≤ MIC ≤ 2 (mean 1.32 ± 0.54
SD); micafungin, 0.5 ≤ MIC ≤ 2 (mean 1.17 ± 0.52 SD);
caspofungin, 0.25 ≤ MIC ≤ 1 (mean 0.5 ± 0.22 SD).
All MIC values for echinocandin were ≤ 2 μg/ml (the
defined cut-off value for susceptibility). However, caspo-
fungin was the most active, with 85.5% of isolates show-
ing MIC values ≤ 0.5 μg/ml.
Biofilm formation
To evaluate the effect of temperature on the formation
of extra-cellular matrix, the production of biofilm was
analyzed after 24 hour incubation at both 30°C and 37°
C. As shown in Table 1, the majority of isolates pro-
duced biofilm (64.5%) following 24 hour incubation at
30°C, with similar results obtained after incubation at
37°C (64.3% of biofilm producers, data not
shown). C. parapsilosis reference strain ATCC 22019
failed to produce biofilm at both temperatures tested.
Statistically significant differences in the distribution of
biofilm producers vs non producers were observed in
strains isolated from different geographic regions. As
shown in Figure 3A, the number of biofilm forming iso-
lates (at 30°C) was significantly higher in isolates
obtained from Hungary (P = 0.001) and Argentina (P =
0.011), compared with Italian strains, where a higher
prevalence of non producers was found. The majority of
isolates from New Zealand were biofilm producers. A
similar trend was observed at 37°C (data not shown).
When biofilm production was correlated with the anato-
mical origin of the samples, regardless of the geographi-
cal location, statistically significant differences in
producers vs non producers could be observed between
nail and blood isolates, with the latter encompassing a
majority of biofilm producer strains, or between nail
and cerebrospinal fluid samples (Figure 3B). Notably, all
cerebrospinal fluid samples were isolated in Argentina.
Again, results obtained at 30 and 37°C (data not shown)
were similar. These experiments need to be confirmed
with a wider range of isolates for each anatomical origin.
Experimental variability was monitored by including a
strong biofilm producer strain as a positive control in
several experiments. Reproducibility experiments per-
formed (n = 7) on separate days showed a mean absor-
bance of 0.348 ± 0.084 SD and a coefficient of variation
of 24.1% [29]. The low standard deviation and a coeffi-
cient of variation of 24% indicated that good precision
may be expected when using this method to estimate
biofilm formation.
Proteinase secretion
Secretion of proteinase was measured as the proteolytic
halo on solid BSA containing medium following 7 days
incubation at 30°C. Most isolates were proteinase produ-
cers, with only 20 strains (33.9%) unable to hydrolyse
BSA (Table 1). When the proteolytic activity was ana-
lysed in isolates obtained from different geographical
regions an inverse trend was observed with respect to
that obtained for biofilm production. In fact, a higher
number of proteinase producers was found in Italy, and
New Zealand, while they were significantly less repre-
sented in Hungary (P = 0.010 and 0.025, respectively,
Figure 4A), where most biofilm producing strains were
isolated. The analysis of protease production in isolates
obtained from different body sites revealed no signifi-
cant association between anatomical origin and produc-
tion of this virulence factor (Figure 4B). The ATCC
22019 reference isolate showed no proteolytic activity
(data not shown).
Figure 3 Biofilm production by C. parapsilosis . Biofilm
production following 24 h incubation at 30°C in inducing medium
by C. parapsilosis isolates obtained from different geographical areas
(A) and different anatomical sites (B). Liquor stands for cerebrospinal
fluid. Number of biofilm producing isolates (P) versus non producers
(NP) were compared using Fisher’s exact test. A P value < 0.05 was
considered statistically significant. I = Italy, NZ = New Zealand, RA =
Argentina, H = Hungary.
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Univariate regression was applied to determine
whether an association existed between the expression
of the two virulence factors studied. As shown in Fig-
ure 5, a negative correlation between biofilm production
and proteinase secretion by the C. parapsilosis isolates
was observed (r = -0.483, P < 0.0001).
Discussion
To date, no significant sequence variation has been
described for Candida parapsilosis [30]. Therefore, this
study was designed to provide further information on
genotypic and phenotypic properties of this opportunis-
tic fungal pathogen.
To evaluate the effect of different environments upon
genetic variability C. parapsilosis isolates were selected
to be representative of different geographical regions
(Italy, Hungary, New Zealand, Argentina) and of differ-
ent anatomical sites (blood, cerebrospinal fluid, mucosa,
nail etc.). The EcoRI/HindIII enzyme combination used
in the AFLP protocol was expected to produce a higher
number of polymorphic bands since in C. metapsilosis
band homoplasy was reduced with this combination and
the average fragment length was larger than the one
obtained with EcoRI/MseI [17]. Indeed the EcoRI/Hin-
dIII enzyme combination confirmed its higher discrimi-
native power for C. parapsilosis and led to the
identification of 20.7% of polymorphic fragments versus
only 5% observed with EcoRI/MseI (data not shown).
However, when genotype analysis was performed on the
presence/absence of a band, the AFLP profiles obtained
clearly indicated very high similarity, with all isolates
grouped within a similarity index of 0.97.
This genetic variability is much lower than what we
have observed for the species C. metapsilosis and C.
orthopsilosis, for which we observed a greater number
of polymorphic bands [16,17]. Our results are in agree-
ment with the observation that the frequency of single
nucleotide polymorphisms (SNPs) in C. parapsilosis is
30 to 70 fold lower than in other Candida species
[30]. The low level of variability found suggests a clo-
nal or selfing strategy of reproduction, supporting the
hypothesis of a successful species recently emerged as
a genetically homogeneous population diverged from a
common ancestor [31]. It is not possible to determine
whether the low variability found is due to a real
absence of sexual recombination, as supported by the
finding of a defective mating-like type locus [30,32],
since the very limited number of variable fragments
hinders a statistical analysis to prove/disprove the exis-
tence of recombination within this species, as pre-
viously performed for C. orthopsilosis and C.
metapsilosis [16,17]. Interestingly, a recent manuscript
by Sabino and colleagues [33] reports a high degree of
polymorphisms by microsatellite analysis in C. parapsi-
losis, with 192 different genotypes found among 233
isolates, based on 4 hyper variable loci. This is remark-
able, considering that the majority of the literature
Figure 4 Proteinase secretion by C. parapsilosis. Proteinase
secretion by C. parapsilosis isolates obtained from different
geographical areas (A) and different anatomical origin (B). ‘Liquor’
refers to cerebrospinal fluid. Proteolytic activity was assessed on
YCB-BSA agar after 7 days incubation at 30°C. Numbers of protease
producing isolates (P) versus non producers (NP) were compared
using Fisher’s exact test. A P value < 0.05 was considered statistically
significant. I = Italy, NZ = New Zealand, RA = Argentina, H =
Hungary.
Figure 5 Correlation between biofilm and proteinase
production. Negative correlation between biofilm production and
proteinase secretion in Candida parapsilosis isolates (n = 62), as
revealed by univariate regression analysis. Pearson’s correlation
coefficient (r) and P-value are indicated.
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points towards limited genetic variability in this spe-
cies. The hypervariability found can provide an excel-
lent tool to discriminate between isolates in outbreak
investigations. However, it does not seem to be useful
for genetic relatedness studies on larger time scale or
on population structure [33].
When the genetic distance between each isolate pair
was calculated using the Pearson’s coefficient, which
takes into account both the presence/absence of bands
and their relative “intensity”, significant geographic
clustering of the isolates was obtained (P < 0.001).
This coefficient has been used as an index of genetic
distance and has been previously reported in AFLP
analysis of bacteria [34,35] and Candida species [36].
Candida fingerprinting techniques such as RFLP with
species specific probes, RAPD, karyotyping also pro-
duce band patterns which differ in band mobility and
intensity. In this respect, genotyping with AFLP gives
rise to a much more complex pattern, composed by a
larger number of bands, which can be compared by
mobility and intensity [37]. The accuracy of the Pear-
son’s coefficient is also dependent on the number of
fragments included in the comparison. Thus, generat-
ing over 80 fragments with a single enzyme/primer
combination, AFLP seems to be a suitable tool to per-
form this kind of analysis [37].
In this context, it is interesting to speculate what causes
the variation in the relative band intensities. Karyotypes
differing in band mobility and intensity have already been
described for C. parapsilosis and other Candida species
[[38], data not shown] and Butler and co-authors showed
that C. albicans can be partially hemizygous [30]. The
role that ploidy plays in C. parapsilosis genetic variability
is a phenomenon already described. In fact, it was shown
that its nuclear size ranges from 57% to 86% from its esti-
mated diploid size [30,39]. We assume that one haploid
complete set of the genome (50%) is always present in
the isolates but what the remaining 7 to 36% of the DNA
actually represents remains unknown. Whether this
represents between 7 to 36% of one homologous set and/
or whether these are DNA sequences present in variable
copy numbers is still to be determined.
Using AFLP with the enzyme combinations EcoRI,
HpaII, and MspI, we have noted that in C. parapsilosis,
methylation of cytidine occurs. It was also observed that
this methylation was variable in different isolates (data
not shown). Variable DNA methylation of restriction
sites might be responsible for different AFLP profiles,
including the observed differences in relative intensities
of AFLP bands found in this study with the enzymes
HindIII and EcoRI.
For what concerns phenotypic traits, drug susceptibil-
ity tests showed that all isolates were susceptible to the
antifungals tested, with the exception of one fluconazole
dose-dependant susceptible isolate. Regardless of the
geographical or anatomical origin, a reduced susceptibil-
ity to echinocandins was observed for all isolates, con-
firming what has already been described for this species
[40]. It has been suggested that this phenotype is due to
a naturally occurring Proline to Alanine amino acid
change (P660A) in the glucan synthase enzyme Fks1p
[40]. However, MIC values were all ≤ 2 mg/ml, the
accepted breakpoint for echinocandins against Candida
species [26,27].
Since this fungal pathogen is able to colonise body sites
with different core temperatures, we examined whether
biofilm formation was influenced by incubation at 30 or
37°C. The results obtained indicated that this parameter
does not significantly alter the ability to produce biofilm
in vitro, with minor differences in the quantity of the
extracellular matrix produced at different temperatures.
Interestingly, biofilm production was linked to both geo-
graphical and anatomical origin of isolates; indeed,
Argentinian or Hungarian isolates produced significantly
more biofilm than Italian strains. To date we do not have
an explanation to justify the higher biofilm production
that was observed in Hungarian isolates. The majority of
these high biofilm producers came from surgery or inten-
sive care units, where catheter related infections with bio-
film producer isolates are more commonly found. Of
note, even though the analysis was performed on a lim-
ited number of isolates, blood and cerebrospinal fluid iso-
lates were found to be more frequently biofilm producers
than strains isolated from nails. These findings need to
be confirmed by comparing a wider set of isolates for
each anatomical site of origin.
The majority of C. parapsilosis isolates (66.1%) pro-
duced proteinase in vitro. In contrast to what was
observed for biofilm production, proteinase producers
were mostly detected in Italy and New Zealand. Inter-
estingly, a statistically significant inverse correlation was
found between proteolytic activity and the ability to
form biofilm, independent of the geographical/anatomi-
cal origin of isolates. Indeed, this finding has also been
described for Staphylococcus aureus [41], where extra-
cellular proteases make a significant contribution to a
biofilm deficient phenotype of an S. aureus mutant, as
shown by the addition of proteinase inhibitors to biofilm
formation assay [41]. In addition, Boles and Horswill
[42] demonstrated through genetic analysis that an S.
aureus double mutant in a metalloprotease and serine
protease, displaying minimal extracellular protease activ-
ity, was improved in biofilm formation, and had a
strongly attenuated detachment phenotype. These find-
ings demonstrate that the S. aureus dispersal mechanism
from consolidated biofilm requires extracellular protease
activity. Recently, the existence of a new pathway has
been demonstrated, controlling protein-mediated biofilm
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formation in which different global regulators modulate
biofilm formation by controlling the expression of S.
aureus extracellular proteases [43]. Therefore, in analogy
to what is described for S. aureus, we hypothesise that
the negative impact of extracellular proteases on biofilm
formation is multifactorial, potentially promoting
detachment and release from a mature biofilm, via
degradation of C. parapsilosis adhesins and/or extracel-
lular matrix components.
Conclusions
Overall, these results confirm previous evidence that
Candida parapsilosis is characterised by a limited DNA
sequence variability, even when considering isolates col-
lected from distant geographical regions. The fact that
phenotypic properties were found to significantly differ
in strains isolated from various geographical regions
suggests that other mechanisms such as epigenetic mod-
ifications may be used by this yeast to adapt to environ-
mental changes.
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